DYAI · Dyadic International Inc · Metrics
$0.48
-0.01 (-1.18%)
At close · Sep 11
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, our management has concluded that there is substantial doubt about our ability to continue as a going concern, which depends upon our obtaining necessary financing to meet our obligations and repay our liabilities arising from normal business operations as they come due.”View the 10-Q filed Aug 12, 2026
Market Cap
$17.64M
Shares
36.44M
DYAI metrics
60 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$0.48
Market cap
$17.64M
Price action
20 metricsPrice change (1W)
-6.9%
Price change (30D)
-37.9%
Price change (3M)
-28.8%
Price change (6M)
-36.3%
Price change (YTD)
-48.5%
Price change (1Y)
-51.1%
Trailing year
Price change (5Y)
-91.6%
52-week high
$1.47
52-week low
$0.48
Change from 52-week high
-67.1%
Change from 52-week low
+0.0%
Annualized volatility
83.0%
Annualized volatility (3M)
112.9%
Beta
0.9
RSI (14D)
23.2
Price vs SMA 50
-46.2%
Price vs SMA 200
-43.2%
Avg volume (3M)
212,586
Relative volume
0.7
Average dollar volume
$197,827
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
36.44M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.6×
reciprocal yield 21.6%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-43.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
16.2%
Operating margin
-195.1%
Trailing 12 months
Net margin
-200.5%
Gross profit (TTM)
—
Operating profit (TTM)
−$7.42M
Net income (TTM)
−$7.62M
Trailing 12 months
Diluted EPS (TTM)
$-0.21
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-0.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.80M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.0%
Year over year · more shares
Revenue CAGR (3Y)
+1.8%
Revenue CAGR (5Y)
+14.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-116.6%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$3.11M
Latest balance sheet
Cash & equivalents
$1.43M
Total assets
$6.54M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$7.40M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$648,362
R&D / revenue
—
Stock compensation / revenue
17.1%
Ownership (13F)
3 metrics13F filers
39
13F filer change QoQ
+2
Institutional ownership
12.9%
Short interest
3 metricsShort interest
0.5%
Latest settlement · 1.2 days to cover
Days to cover
1.2d
Short-squeeze score
26 / 100
Insider activity
2 metricsNet insider buying (90D)
−$124,958
Insider-sentiment score
39 / 100
Risk flags
1 metricsGoing concern
Flagged